{"id":"anticholinergic","rwe":[],"tags":[],"trials":[],"_chembl":{"chemblId":"CHEMBL2105187","moleculeType":"Small molecule","molecularWeight":"405.59"},"aliases":["Beta-agonists","Vesicare","BUP-4","Solifenacin","VESIcare"],"patents":[],"pricing":[],"offLabel":[],"timeline":[],"_dailymed":null,"ecosystem":[],"_scrapedAt":"2026-03-28T00:17:19.558Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"references":[],"biosimilars":[],"competitors":[],"labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT07489677","phase":"NA","title":"The Feasibility and Acceptability of a Collaborative Deprescribing Intervention to Reduce Anticholinergic Burden Among Hospitalised Older Patients","status":"COMPLETED","sponsor":"University Hospital Southampton NHS Foundation Trust","startDate":"2025-05-22","conditions":"Older Adults (60 - 85 Years Old)","enrollment":21},{"nctId":"NCT05362292","phase":"PHASE4","title":"TReating Incontinence for Underlying Mental and Physical Health","status":"RECRUITING","sponsor":"University of California, San Francisco","startDate":"2022-10-04","conditions":"Urinary Incontinence, Urge, Urinary Incontinence, Overactive Bladder","enrollment":270},{"nctId":"NCT06349057","phase":"PHASE4","title":"The Effect of the Anticholinergic Burden Following Elective Coronary Artery Surgery","status":"COMPLETED","sponsor":"Ankara City Hospital Bilkent","startDate":"2024-01-01","conditions":"Postoperative Recovery, Length of Hospital Stay, Postoperative Complications","enrollment":120},{"nctId":"NCT07429734","phase":"PHASE3","title":"Efficacy of Gabapentin Combined With Solifenacin for Non-neurogenic Overactive Bladder in Women","status":"NOT_YET_RECRUITING","sponsor":"Mansoura University","startDate":"2026-02","conditions":"Overactive Bladder","enrollment":60},{"nctId":"NCT07403032","phase":"NA","title":"Study on the Effects and Mechanisms of Modified Ma Xing Shi Gan Decoction in Treating Acute Exacerbations of Chronic Obstructive Pulmonary Disease","status":"NOT_YET_RECRUITING","sponsor":"Cuiling Feng","startDate":"2026-01-12","conditions":"Chronic Obstructive Pulmonary Disease","enrollment":200},{"nctId":"NCT06562608","phase":"PHASE4","title":"Anticholinergic Deprescription in Schizophrenia","status":"RECRUITING","sponsor":"Deepak K. Sarpal, M.D.","startDate":"2025-02-01","conditions":"Schizophrenia, Schizoaffective Disorder","enrollment":105},{"nctId":"NCT07391878","phase":"PHASE2","title":"Evaluate the Safety and Efficacy of TRG-200 KIT in Patients With Refractory Overactive Bladder.","status":"NOT_YET_RECRUITING","sponsor":"Trigone Pharma Ltd.","startDate":"2026-02-15","conditions":"Overactive Bladder (OAB)","enrollment":60},{"nctId":"NCT06731101","phase":"NA","title":"Stellate Ganglion Block Versus Oral Medication in Treatment of Palmar Hyperhidrosis","status":"COMPLETED","sponsor":"Fayoum University","startDate":"2025-01-15","conditions":"Palmar Hyperhidrosis","enrollment":46},{"nctId":"NCT06783296","phase":"NA","title":"Efficacy and Safety of Renal Denervation on Isolated Diastolic Hypertension","status":"NOT_YET_RECRUITING","sponsor":"Shanghai 10th People's Hospital","startDate":"2026-01-01","conditions":"Hypertension, Renal Denervation Therapy","enrollment":124},{"nctId":"NCT06366087","phase":"PHASE1","title":"Sublingual Atropine Bioequivalence by Route of Administration (SABER)","status":"COMPLETED","sponsor":"Biomedical Advanced Research and Development Authority","startDate":"2024-04-15","conditions":"Atropine Bioequivalence","enrollment":46},{"nctId":"NCT07259148","phase":"NA","title":"Behavioral Interventions Versus Pelvic Floor Muscle Therapy as Adjuncts to Anticholinergic Pharmacotherapy for Urgency Urinary Incontinence: A Non-Inferiority Trial","status":"ACTIVE_NOT_RECRUITING","sponsor":"Emilio José Dávila Álvarez","startDate":"2025-11-22","conditions":"Urgency Urinary Incontinence","enrollment":80},{"nctId":"NCT04924036","phase":"PHASE2","title":"Qbrexza Cloths for Hyperhidrosis of Amputation Sites","status":"COMPLETED","sponsor":"University of Utah","startDate":"2021-09-27","conditions":"Amputation, Hyperhidrosis","enrollment":13},{"nctId":"NCT07337252","phase":"","title":"Risk Factors for Treatment Failure in Women With Detrusor Overactivity Receiving Combined Pharmacotherapy","status":"COMPLETED","sponsor":"Mackay Memorial Hospital","startDate":"2022-06-01","conditions":"Overactive Bladder","enrollment":61},{"nctId":"NCT07187466","phase":"PHASE4","title":"Behavioral and/or Mirabegron to Treat Urinary Symptoms in Parkinson Disease","status":"NOT_YET_RECRUITING","sponsor":"VA Office of Research and Development","startDate":"2026-04-01","conditions":"Overactive Bladder, Parkinson Disease","enrollment":146},{"nctId":"NCT04129060","phase":"EARLY_PHASE1","title":"Cholinergic Health After Menopause (CHAMP)","status":"COMPLETED","sponsor":"University of Vermont","startDate":"2020-03-15","conditions":"Postmenopausal Symptoms, Aging, Alzheimer Disease","enrollment":120},{"nctId":"NCT03246581","phase":"PHASE1","title":"Two-period 21 Day Cross-over Study to Compare the Pharmacokinetics of Tiotropium From Two Inhalers","status":"COMPLETED","sponsor":"Kindeva Drug Delivery","startDate":"2017-07-13","conditions":"Healthy","enrollment":40},{"nctId":"NCT01651676","phase":"NA","title":"Estimation of the VQ11 Auto-questionnaire, to Follow Patients With Chronic Obstructive Pulmonary Disease","status":"COMPLETED","sponsor":"Centre Hospitalier Universitaire, Amiens","startDate":"2013-02","conditions":"COPD","enrollment":57},{"nctId":"NCT04903470","phase":"NA","title":"Defecation Patterns in Constipated Patients","status":"RECRUITING","sponsor":"The California Medical Innovations Institute, Inc.","startDate":"2022-12-19","conditions":"Constipation by Outlet Obstruction","enrollment":130},{"nctId":"NCT05594017","phase":"EARLY_PHASE1","title":"Pharmacological Modulation of Brain Oscillations in Memory Processing","status":"RECRUITING","sponsor":"University of Texas Southwestern Medical Center","startDate":"2019-08-01","conditions":"Epilepsy, Seizures, Cognitive Impairment, Mild","enrollment":60},{"nctId":"NCT07199894","phase":"PHASE3","title":"Omegapres Versus Solifenacin and Mirabegron Combination Therapy in Treatment of Primary MNE","status":"RECRUITING","sponsor":"Mansoura University","startDate":"2024-12-01","conditions":"Nocturnal Enuresis in Children","enrollment":120},{"nctId":"NCT06812481","phase":"","title":"Anticholinergic Burden and Osteoporosis in Rheumatoid Arthritis","status":"RECRUITING","sponsor":"Balikesir University","startDate":"2025-09-15","conditions":"Rheumatoid Arthritis (RA), Anticholinergic Adverse Reaction, Fractures, Bone","enrollment":100},{"nctId":"NCT06398899","phase":"NA","title":"Sugammadex v.s. Neostigmine/Glycopyrrolate","status":"COMPLETED","sponsor":"National Taiwan University Hospital","startDate":"2024-05-01","conditions":"Head and Neck Surgery, Chronic Sinusitis, Chronic Otitis Media","enrollment":124},{"nctId":"NCT07165574","phase":"","title":"Prevalence of Anticholinergics in Geriatric Patients With Acute Functional Deterioration","status":"NOT_YET_RECRUITING","sponsor":"Aalborg University Hospital","startDate":"2025-09-01","conditions":"Frailty in Older Adults, Functional Decline, Anticholinergic Syndrome","enrollment":100},{"nctId":"NCT04756232","phase":"EARLY_PHASE1","title":"Cholinergic Mechanisms of Attention in Aging","status":"COMPLETED","sponsor":"Vanderbilt University Medical Center","startDate":"2022-04-21","conditions":"Subjective Cognitive Decline","enrollment":19},{"nctId":"NCT06355180","phase":"NA","title":"Esketamine vs ECT for Acute Suicidality","status":"COMPLETED","sponsor":"Capital Medical University","startDate":"2024-04-16","conditions":"Mood Disorders, Suicidal Ideation, Depressive Episode","enrollment":340},{"nctId":"NCT05919394","phase":"PHASE4","title":"Triple vs High Dose Inhaled CORticosteroids","status":"WITHDRAWN","sponsor":"Galaxia Empírica","startDate":"2023-06-01","conditions":"Asthma","enrollment":""},{"nctId":"NCT03208569","phase":"","title":"Anticholinergic Burden - Treatment Optimization","status":"COMPLETED","sponsor":"Region Skane","startDate":"2017-09-01","conditions":"Anticholinergics, Cognitive Function","enrollment":663},{"nctId":"NCT07114848","phase":"PHASE4","title":"Comparing Tamsulosin and Solifenacin for Relieving Double J Stent Symptoms: Using the USSQ.","status":"COMPLETED","sponsor":"Liaquat National Hospital & Medical College","startDate":"2024-06-13","conditions":"Ureteral Stent-Related Symptom, Alpha Blocker, Anticholinergics","enrollment":60},{"nctId":"NCT07075835","phase":"NA","title":"Enhanced External Counterpulsation for Patients With Ventilation Disorders","status":"ACTIVE_NOT_RECRUITING","sponsor":"I.M. Sechenov First Moscow State Medical University","startDate":"2023-11-01","conditions":"Chronic Lung Diseases","enrollment":80},{"nctId":"NCT07043803","phase":"NA","title":"Reduction of Anticholinergic Medications Among Persons With Schizophrenia or Other Psychiatric Disorders","status":"RECRUITING","sponsor":"University of Pittsburgh","startDate":"2025-07-16","conditions":"Schizophenia Disorder, Schizoaffective Disorder, Bipolar Disorder","enrollment":111},{"nctId":"NCT06248723","phase":"NA","title":"ItaliaN Study With Tailored Multidomain Interventions to Prevent Functional and Cognitive Decline in Community-dwelling Older Adults","status":"RECRUITING","sponsor":"University of Milano Bicocca","startDate":"2024-07-16","conditions":"Age-related Cognitive Decline","enrollment":1340},{"nctId":"NCT07081906","phase":"NA","title":"Transdermal Versus Oral Oxybutynin in Pediatric OAB","status":"COMPLETED","sponsor":"Dr. Lutfi Kirdar Kartal Training and Research Hospital","startDate":"2019-02-15","conditions":"Overactive Bladder (OAB), Drug Delivery Systems, Anticholinergic Side Effects","enrollment":90},{"nctId":"NCT07046156","phase":"","title":"Treatment of Overactive Bladder With Anticholinergic Agents","status":"ACTIVE_NOT_RECRUITING","sponsor":"Sehit Prof. Dr. Ilhan Varank Sancaktepe Training and Research Hospital","startDate":"2022-09-01","conditions":"Overactive Bladder","enrollment":120},{"nctId":"NCT06002477","phase":"EARLY_PHASE1","title":"Attentional Mechanisms in SCD","status":"RECRUITING","sponsor":"Vanderbilt University Medical Center","startDate":"2025-03-27","conditions":"Subjective Cognitive Decline","enrollment":80},{"nctId":"NCT07028645","phase":"","title":"Uroflowmetry and Nocturnal Enuresis","status":"ACTIVE_NOT_RECRUITING","sponsor":"Furkan Adem Canbaz","startDate":"2022-08-20","conditions":"Enuresis, Nocturnal","enrollment":100},{"nctId":"NCT06645509","phase":"PHASE2","title":"Severe Primary Hand Hyperhidrosis Treatment With Topical Administration of Victorhy","status":"TERMINATED","sponsor":"Dryox Health","startDate":"2024-04-29","conditions":"Palmar Hyperhidrosis","enrollment":58},{"nctId":"NCT07027020","phase":"PHASE3","title":"Efficacy of Intravesical Oxybutynin in Children With Neurogenic Bladder Dysfunction","status":"NOT_YET_RECRUITING","sponsor":"Central Hospital, Nancy, France","startDate":"2025-09","conditions":"Spina Bifida","enrollment":60},{"nctId":"NCT05993754","phase":"NA","title":"Non-pharmacological Prevention of POD in Frailty Elderly Undergoing Elective Surgery Applied by Nursing Teams","status":"RECRUITING","sponsor":"Pontificia Universidad Catolica de Chile","startDate":"2024-04-01","conditions":"Frail Elderly Syndrome, Primary Prevention, Postoperative Delirium","enrollment":400},{"nctId":"NCT06110481","phase":"","title":"Reversibility of Bronchial Obstruction in Children Born Preterm","status":"RECRUITING","sponsor":"Charles University, Czech Republic","startDate":"2021-04-01","conditions":"Bronchopulmonary Dysplasia, Chronic Lung Disease of Prematurity, Chronic Lung Disease of Newborn","enrollment":80},{"nctId":"NCT05538065","phase":"NA","title":"NUDGE-EHR Replication Trial at Mass General Brigham","status":"COMPLETED","sponsor":"Brigham and Women's Hospital","startDate":"2022-11-10","conditions":"Aging, Benzodiazepine Sedative Adverse Reaction, Anticholinergic Adverse Reaction","enrollment":201},{"nctId":"NCT06479720","phase":"PHASE4","title":"Efficacy of Solifenacin or Mirabegron With Local Estrogen Versus Combination Pharmacotherapy for Overactive Bladder","status":"RECRUITING","sponsor":"Mackay Memorial Hospital","startDate":"2022-06-16","conditions":"Effect of Drug, Urinary Bladder, Overactive","enrollment":300},{"nctId":"NCT05565430","phase":"","title":"Vocal Cord Responses During Hyperventilation in Normal Individuals and in Mild and Severe Asthmatics.","status":"COMPLETED","sponsor":"Monash Medical Centre","startDate":"2018-06-01","conditions":"Hyperventilation, Larynx, Asthma","enrollment":24},{"nctId":"NCT03913819","phase":"","title":"Treatment Outcomes Under a Standardized Treatment Protocol in Patients Suffered Substance Abuse Related Voiding Dysfunction","status":"RECRUITING","sponsor":"Chinese University of Hong Kong","startDate":"2011-12-10","conditions":"Voiding Dysfunction, Substance Abuse","enrollment":1000},{"nctId":"NCT05842928","phase":"NA","title":"Patient-centred Deprescribing of Psychotropic, Sedative and Anticholinergic Medication in Elderly Patients With Polypharmacy","status":"RECRUITING","sponsor":"Ludwig-Maximilians - University of Munich","startDate":"2023-03-25","conditions":"Deprescriptions, Antidepressive Agents, Antipsychotic Agents","enrollment":352},{"nctId":"NCT06931353","phase":"","title":"Effect of the Anticholinergic Drug Burden on Postoperative Delirium in Elderly Chinese Patients: A Nested Case-Control Study","status":"COMPLETED","sponsor":"Hao Li","startDate":"2020-04-01","conditions":"Delirium - Postoperative","enrollment":10536},{"nctId":"NCT06912880","phase":"","title":"Effects of Therapies in Women With Stress Urinary Incontinence","status":"COMPLETED","sponsor":"Eastern Mediterranean University","startDate":"2017-11-09","conditions":"Stress Urinary Incontinence","enrollment":32},{"nctId":"NCT04270474","phase":"NA","title":"Reducing Risk of Dementia Through Deprescribing","status":"ACTIVE_NOT_RECRUITING","sponsor":"Indiana University","startDate":"2020-07-20","conditions":"Dementia, Alzheimer Disease, Late Onset","enrollment":344},{"nctId":"NCT04121858","phase":"NA","title":"Brain Safe: Consumer Intervention to Reduce Exposure to Drugs Linked to Alzheimer's Disease","status":"COMPLETED","sponsor":"Indiana University","startDate":"2019-10-16","conditions":"Alzheimer Disease, Dementia","enrollment":706},{"nctId":"NCT06586320","phase":"NA","title":"Quantification of Parkinson's Disease Patients As a Biomarker for Classification, Prediction and Response to Treatment","status":"ENROLLING_BY_INVITATION","sponsor":"Stardots AB","startDate":"2025-02-06","conditions":"Parkinson Disease","enrollment":40},{"nctId":"NCT06210477","phase":"","title":"Association With Low Compliance Bladder in Women With LUTS","status":"COMPLETED","sponsor":"National Taiwan University Hospital","startDate":"2024-01-31","conditions":"Urinary Bladder, Overactive, Urinary Bladder Neck Obstruction, Pelvic Organ Prolapse","enrollment":200},{"nctId":"NCT06778824","phase":"NA","title":"Neuroregulators for the Treatment of Diseases Associated With Esophageal-brain-gut Axis Communication Abnormalities.","status":"RECRUITING","sponsor":"Hualien Tzu Chi General Hospital","startDate":"2024-04-02","conditions":"Gut-Brain Disorders, GERD Without Erosive Esophagitis","enrollment":610},{"nctId":"NCT06785558","phase":"NA","title":"The Role of Urinary ATP in the Diagnosis, Treatment, and Follow-up of Children with Overactive Bladder","status":"COMPLETED","sponsor":"Marmara University","startDate":"2024-01-01","conditions":"Overactive Bladder (OAB)","enrollment":40},{"nctId":"NCT06772454","phase":"","title":"To Evaluate the Efficacy and Safety of Inhaled Corticosteroids Combined With Bronchodilators and Programmed Death-ligand 1 (PD-L1) Inhibitor Plus Platinum-based Chemotherapy in Patients With Advanced Lung Squamous Cell Carcinoma Complicated With Chronic Obstructive Pulmonary Disease (COPD)","status":"RECRUITING","sponsor":"Guangzhou Institute of Respiratory Disease","startDate":"2023-01-01","conditions":"Lung Cancer Squamous Cell, COPD","enrollment":60},{"nctId":"NCT03151616","phase":"","title":"Anticholinergic Risk Scale and Resource Use After Elective Noncardiac Surgery","status":"COMPLETED","sponsor":"Ottawa Hospital Research Institute","startDate":"2003-04-01","conditions":"Length of Stay, Anti Cholinergics, Surgical Procedure, Operative","enrollment":244976},{"nctId":"NCT06408051","phase":"","title":"Efficacy of 200 IU OnabotulinumtoxinA in Idiopathic Overactive Bladder Resistant to Anticholinergic Treatment","status":"COMPLETED","sponsor":"Hisar Intercontinental Hospital","startDate":"2020-01-01","conditions":"Idiopathic Overactive Bladder Resistant to Anticholinergic Treatment","enrollment":60},{"nctId":"NCT05067478","phase":"","title":"Composur: Study to Understand the Performance of Vibegron in Participants with Overactive Bladder (OAB)","status":"COMPLETED","sponsor":"Urovant Sciences GmbH","startDate":"2021-10-28","conditions":"Overactive Bladder","enrollment":403},{"nctId":"NCT06737016","phase":"PHASE3","title":"Efficacy and Safety of Tamsulosin for Children with Posterior Urethral Valve.","status":"RECRUITING","sponsor":"Mansoura University","startDate":"2024-11-01","conditions":"Posterior Urethral Valve","enrollment":50},{"nctId":"NCT06034379","phase":"NA","title":"Electronic Spectacles Versus Low Dose Atropine in Young Myopes","status":"RECRUITING","sponsor":"Kubota Vision Inc.","startDate":"2023-10-01","conditions":"Myopia","enrollment":45},{"nctId":"NCT05086341","phase":"NA","title":"A Pilot- and Feasibility Trial of the EHealth Tool My COPD for People with COPD","status":"COMPLETED","sponsor":"Umeå University","startDate":"2021-11-05","conditions":"Chronic Obstructive Pulmonary Disease","enrollment":22},{"nctId":"NCT03564236","phase":"NA","title":"Nasal High-Flow in COPD","status":"RECRUITING","sponsor":"Marieke Duiverman","startDate":"2018-10-01","conditions":"COPD Exacerbation","enrollment":136},{"nctId":"NCT02676297","phase":"PHASE1","title":"Cross-over Study in Volunteers to Compare the Pharmacokinetics of Tiotropium Delivered From Test and Reference Products","status":"COMPLETED","sponsor":"Solventum US LLC","startDate":"2016-01","conditions":"Healthy","enrollment":26},{"nctId":"NCT03302065","phase":"PHASE1","title":"Comparison of the Pharmacokinetics of Tiotropium Delivered From Test Inhaler Products With Reference","status":"COMPLETED","sponsor":"Solventum US LLC","startDate":"2016-05","conditions":"Healthy","enrollment":38},{"nctId":"NCT02627625","phase":"PHASE1","title":"Comparison of the Pharmacokinetics of Tiotropium Delivered From Test Inhaler Products With Two Reference Products","status":"COMPLETED","sponsor":"Solventum US LLC","startDate":"2015-11","conditions":"Healthy","enrollment":31},{"nctId":"NCT06702670","phase":"PHASE2, PHASE3","title":"Anticholinergics for Cervical Edema in Labor","status":"NOT_YET_RECRUITING","sponsor":"The University of Texas Health Science Center, Houston","startDate":"2024-12-01","conditions":"Labor Dystocia","enrollment":200},{"nctId":"NCT06617806","phase":"NA","title":"Advanced Practice Nurses for Fall Incidence PrevenTion in Very Old Robust Adults","status":"RECRUITING","sponsor":"Nantes University Hospital","startDate":"2024-10-15","conditions":"Fall Prevention, Autonomy of Older People, Frail Elderly","enrollment":386},{"nctId":"NCT04284553","phase":"NA","title":"Optimizing Electronic Health Record Prompts With Behavioral Economics to Improve Prescribing for Older Adults","status":"COMPLETED","sponsor":"Brigham and Women's Hospital","startDate":"2020-10-13","conditions":"Aging, Benzodiazepine Sedative Adverse Reaction, Anticholinergic Adverse Reaction","enrollment":216},{"nctId":"NCT02294396","phase":"PHASE4","title":"Postmarketing Study to Evaluate add-on Therapy With Anticholinergics in Patients With Overactive Bladder (OAB) on Mirabegron.","status":"COMPLETED","sponsor":"Astellas Pharma Inc","startDate":"2014-10-28","conditions":"Overactive Bladder (OAB)","enrollment":649},{"nctId":"NCT03903094","phase":"","title":"A Study on Anticholinergic Use: Attribution of Overactive Bladder (OAB) Medications to the Anticholinergic Burden","status":"COMPLETED","sponsor":"Astellas Pharma Singapore Pte. Ltd.","startDate":"2019-03-07","conditions":"Overactive Bladder (OAB)","enrollment":6295279},{"nctId":"NCT06652776","phase":"","title":"The Italian Registry of Patients with Chronic Obstructive Pulmonary Disease","status":"ENROLLING_BY_INVITATION","sponsor":"University of Milan","startDate":"2024-09-30","conditions":"COPD, COPD Exacerbation Acute, Comorbid Chronic Lung Disease on Heart Failure","enrollment":10000},{"nctId":"NCT04074616","phase":"NA","title":"Reducing Anticholinergic Bladder Medication Use in Spinal Cord Injury With Home Neuromodulation","status":"COMPLETED","sponsor":"The University of Texas Health Science Center, Houston","startDate":"2019-11-19","conditions":"Chronic Spinal Cord Injury, Neurogenic Bladder","enrollment":50},{"nctId":"NCT06616675","phase":"PHASE4","title":"Darifenacin x Parasacral Transcutaneous Electric Nerve Stimulation for OAB in Patients Infected With Human T-Lymphotropic Virus 1","status":"COMPLETED","sponsor":"Hospital Universitário Professor Edgard Santos","startDate":"2022-03-16","conditions":"HTLV-1, Overactive Bladder Syndrome","enrollment":42},{"nctId":"NCT04819360","phase":"PHASE4","title":"Botulinum Toxin a Vs Anticholinergic Treatment of Neurogenic Overactive Bladder in Patients with Multiple Sclerosis","status":"TERMINATED","sponsor":"Brigitte Schürch","startDate":"2021-06-01","conditions":"Urinary Bladder, Neurogenic, Multiple Sclerosis","enrollment":1},{"nctId":"NCT06609941","phase":"NA","title":"Additive Effects of Alternative Nostril Breathing with Pharmacological Management on Dyspnea and Control Pause in Patients with Bronchial Asthma","status":"RECRUITING","sponsor":"Foundation University Islamabad","startDate":"2024-06-18","conditions":"Bronchial Asthma","enrollment":32},{"nctId":"NCT06558539","phase":"PHASE3","title":"Tibial Nerve Stimulation for Post-BPH Overactive Bladder","status":"NOT_YET_RECRUITING","sponsor":"Qing Yuan","startDate":"2024-09","conditions":"Persistent Overactive Bladder Symptoms Post Benign Prostatic Hyperplasia Surgery","enrollment":90},{"nctId":"NCT04353960","phase":"","title":"The Alaska Oculocardiac Reflex Study","status":"RECRUITING","sponsor":"Alaska Blind Child Discovery","startDate":"1992-09-01","conditions":"Bradycardia, Strabismus","enrollment":4000},{"nctId":"NCT06525051","phase":"","title":"Effect of Tiotropium on Eye Findings in the Treatment of Chronic Obstructive Pulmonary Disease","status":"COMPLETED","sponsor":"Giresun University","startDate":"2023-10-23","conditions":"Chronic Obstructive Pulmonary Disease, Glaucoma, Angle-Closure","enrollment":108},{"nctId":"NCT01244815","phase":"PHASE3","title":"Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder (P06107 Has an Extension [P05898; NCT01349907])(P06107)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2011-06-16","conditions":"Bipolar Disorder, Pediatric","enrollment":404},{"nctId":"NCT01918033","phase":"PHASE3","title":"A Study of the Efficacy and Safety of Desloratadine (MK-4117) in Japanese Participants With Perennial Allergic Rhinitis (MK-4117-200)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2013-08-20","conditions":"Perennial Allergic Rhinitis","enrollment":608},{"nctId":"NCT01916967","phase":"PHASE3","title":"An Efficacy and Safety Study of Desloratadine (MK-4117) in Japanese Participants With Chronic Urticaria (MK-4117-201)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2013-08-27","conditions":"Urticaria","enrollment":239},{"nctId":"NCT06447259","phase":"","title":"Drug Burden Index is Associated With Malnutrition in Community-dwelling Dementia Patients","status":"COMPLETED","sponsor":"Sultan Keskin Demircan","startDate":"2023-05-20","conditions":"Malnutrition Severe, Dementia, Drug Use","enrollment":415},{"nctId":"NCT05102396","phase":"PHASE2","title":"Topical Oxybutynin for Treatment of Hyperidrosis: Local or Systemic Effect?","status":"RECRUITING","sponsor":"Samantha Rodrigues Camargo Neves de Moura","startDate":"2022-09-26","conditions":"Hyperhidrosis, Oxybutynin, Sweat Gland Diseases","enrollment":17},{"nctId":"NCT01349907","phase":"PHASE3","title":"Extension Study of Asenapine [P06107 (NCT01244815)] for Pediatric Bipolar Disorder (P05898)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2011-06-16","conditions":"Bipolar Disorder","enrollment":322},{"nctId":"NCT06376942","phase":"PHASE2, PHASE3","title":"A RCT to Compare the Effectiveness of Nebulized Anticholinergics for Cough Suppression During Flexible Bronchoscopy","status":"NOT_YET_RECRUITING","sponsor":"Post Graduate Institute of Medical Education and Research, Chandigarh","startDate":"2024-04-24","conditions":"Subjects Undergoing Flexible Bronchoscopy","enrollment":1050},{"nctId":"NCT04124939","phase":"PHASE4","title":"Is 10 Injections of Bladder Botox Less Painful Than 20 Injections?","status":"COMPLETED","sponsor":"Wake Forest University Health Sciences","startDate":"2019-11-10","conditions":"Overactive Bladder","enrollment":41},{"nctId":"NCT06301802","phase":"","title":"Outcomes of Proactive Management of Children With Myelomeningocele","status":"RECRUITING","sponsor":"Assiut University","startDate":"2024-03-04","conditions":"Urologic Diseases","enrollment":40},{"nctId":"NCT03858348","phase":"","title":"A Retrospective rEal-life daTa Study to Assess the exaceRbations and Lung functIon in Chronic Obstructive Pulmonary Disease ( COPD ) patiEnts receiVing Fluticasone/Salmeterol Comparing to Those Εscalating in Open-triple Fluticasone/Salmeterol, Long Acting Muscarinic Antagonist (LAMA) Combination","status":"COMPLETED","sponsor":"Elpen Pharmaceutical Co. Inc.","startDate":"2019-05-01","conditions":"COPD, COPD Exacerbation","enrollment":1000},{"nctId":"NCT03817931","phase":"PHASE4","title":"Higher Neural Changes Following Anticholinergic, Beta 3 Agonist, or Placebo in Patients With Overactive Bladder","status":"COMPLETED","sponsor":"Baylor Research Institute","startDate":"2019-08-05","conditions":"Overactive Bladder, Dementia, Lower Urinary Tract Symptoms","enrollment":12},{"nctId":"NCT05183841","phase":"NA","title":"Bronchodilators on the Exercise Capacity of Bronchiectasis Patients","status":"UNKNOWN","sponsor":"University of Sao Paulo General Hospital","startDate":"2022-04-14","conditions":"Bronchiectasis Adult","enrollment":40},{"nctId":"NCT04617015","phase":"EARLY_PHASE1","title":"Defining and Treating Depression-related Asthma","status":"COMPLETED","sponsor":"State University of New York at Buffalo","startDate":"2016-09-09","conditions":"Asthma, Depression, Childhood Asthma","enrollment":40},{"nctId":"NCT03665493","phase":"NA","title":"Dopamine Effect on Inhibitory Control","status":"COMPLETED","sponsor":"Giovanni Mirabella","startDate":"2020-09-30","conditions":"Idiopathic Parkinson's Disease","enrollment":90},{"nctId":"NCT05735379","phase":"PHASE4","title":"Impact in Older Adults of Reducing Anticholinergic and Sedative Rx Burden on Physical Function Measured by Wearables","status":"UNKNOWN","sponsor":"Centre de recherche du Centre hospitalier universitaire de Sherbrooke","startDate":"2023-03-23","conditions":"Deprescribing Anticholinergic and Sedative Medications, Physical Function","enrollment":182},{"nctId":"NCT05586477","phase":"PHASE4","title":"Diphenhydramine and Sweating","status":"COMPLETED","sponsor":"Lakehead University","startDate":"2022-11-21","conditions":"Diphenhydramine Causing Adverse Effects in Therapeutic Use, Hyperthermia, Allergic Rhinitis","enrollment":20},{"nctId":"NCT03915821","phase":"NA","title":"Memory Changes in Patients With Major Depression Disorder Treated With ECT","status":"COMPLETED","sponsor":"Assiut University","startDate":"2020-12-15","conditions":"Depressive Disorder","enrollment":60},{"nctId":"NCT05902676","phase":"","title":"The Effects Of Anticholinergic Burden On Daily Living Activities In Elderly Patients","status":"UNKNOWN","sponsor":"Izmir Ataturk Training and Research Hospital","startDate":"2023-06-15","conditions":"Anticholinergic Syndrome, Anticholinergic Adverse Reaction, Antispasmodic Adverse Reaction","enrollment":180},{"nctId":"NCT04612166","phase":"NA","title":"Medication Empowerment and Deprescription for Safety (MEDS) Study","status":"UNKNOWN","sponsor":"University of Iowa","startDate":"2020-08-01","conditions":"Aging, Fall Injury","enrollment":398},{"nctId":"NCT03988530","phase":"PHASE3","title":"Prevention and Treatment of Nausea Associated With Motion Sickness in Senior Subjects","status":"COMPLETED","sponsor":"Repurposed Therapeutics, Inc.","startDate":"2019-06-07","conditions":"Motion Sickness","enrollment":98},{"nctId":"NCT03946124","phase":"PHASE4","title":"Fall Prevention in Older Adults With OAB","status":"COMPLETED","sponsor":"University of Pennsylvania","startDate":"2015-07-25","conditions":"Overactive Bladder","enrollment":74},{"nctId":"NCT04360746","phase":"NA","title":"The Influence of Clinical Pharmacist on the Quality of Drug Prescribing and Rehabilitation Outcomes in Post-acute Hip Fractured Patients","status":"COMPLETED","sponsor":"Rabin Medical Center","startDate":"2020-03-01","conditions":"Hip Fractures, Clinical Pharmacists, Rehabilitation Outcome","enrollment":200},{"nctId":"NCT05745584","phase":"NA","title":"Effect of Mirabegron on Bladder Compliance","status":"UNKNOWN","sponsor":"Yonsei University","startDate":"2016-01-12","conditions":"Patients With Low Bladder Compliance of 20ml/H2O or Less Despite Taking Anticholinergics","enrollment":15},{"nctId":"NCT03290287","phase":"","title":"Aclidinium Bromide Post-Authorisation Safety Study to Evaluate the Risk of Cardiovascular Endpoints","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2017-03-01","conditions":"Pulmonary Disease, Chronic Obstructive","enrollment":26839}],"_emaApprovals":[],"_faersSignals":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"formularyStatus":[],"_approvalHistory":[],"developmentCodes":[],"ownershipHistory":[],"publicationCount":12671,"therapeuticAreas":["Other"],"biosimilarFilings":[],"companionDiagnostics":[],"genericManufacturerList":[],"phase":"marketed","status":"active","brandName":"Anticholinergic","genericName":"Anticholinergic","companyName":"Medstar Health Research Institute","companyId":"medstar-health-research-institute","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":1,"regulatoryByCountry":[{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":9,"withResults":0},"verificationStatus":"enriching","dataCompleteness":{"mechanism":false,"indications":false,"safety":false,"trials":true,"score":1}}